Skip to content

Comparison ofMidasolam-meperidine and Propofol -Fentanyl sedation in patients scheduled for colonoscopy

Comparison ofMidasolam-meperidine and Propofol -Fentanyl sedation in patients scheduled for colonoscopy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201301235381N5
Enrollment
80
Registered
2013-05-11
Start date
2012-08-26
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with intestine diseases who need colonoscopy. disease of intestine,unspecified

Interventions

Intervention 1: Fentanil 1microgram/kg and bolus dose of propofol 0.5 mg/kg was given, followed by continuous infusion at 25microgram/kg/min. Intervention 2: midasolam 0.3mg/kg and meperidine 0.7mg/kg
Treatment - Drugs
midasolam 0.3mg/kg and meperidine 0.7mg/kg was adminstrated by bolus injection

Sponsors

Mazandaran Uiversity of Medical Sciences and Health Services
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 58 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:patients scheduled for comlete elective colonoscopy;ages of 18-55 years;ASA I-II. exclusion criteria:History of large bowel surgery;pregnancy;patients with psychiatric and emotional disorder;history of addiction;history of allergic reaction;history of pulmonary and metabolic disorders.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Before of discharge. Method of measurement: Visual Analogues Scale.

Secondary

MeasureTime frame
Drug adverse effects. Timepoint: Before and after colonoscopy. Method of measurement: Before and after colonoscopy.;Colonoscopist satisfaction. Timepoint: After colonoscopy. Method of measurement: Numerical rating scale for colonoscopist satisfaction.;Heart rate. Timepoint: Every 5 minutes. Method of measurement: Pulse counting.;Blood pressure. Timepoint: Every 5 minutes. Method of measurement: Noninvasive cuff measurrment.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVahid Hosseini

Mazandaran University of Medical Sciences

dr.vahid47@gmail.com+98 15 1226 1700

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026